MindMed Reports First Quarter 2023 Financial Results and Business Highlights

04.05.2023 - Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or 'MindMed'), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today reported its financial results for the ...

Related Keywords

Boston ,Massachusetts ,United States ,Switzerland ,New York ,Canada ,Canadian ,American ,Matthias Liechti ,Markr Sullivan ,Felix Mueller ,Liechti Lab At University Hospital Basel ,Company Quarterly Report On Form ,Medicine Mindmed Inc ,Nasdaq ,International Convention ,American Society Of Clinical Psychopharmacology ,Exchange Commission ,University Hospital Basel ,Company Phase ,Company Annual Report On Form ,Chief Legal ,Markets Global Healthcare Conference ,Jefferies Global Healthcare Conference ,Anticipated Upcoming Milestones ,Demonstrates Prosocial ,Therapeutic Like Effects ,Preclinical Model ,Autism Spectrum Disorder ,American Society ,Miami Beach ,Hospital Basel ,Liechti Lab ,Depressive Symptomatology ,Annual Report ,Quarterly Report ,Note Regarding Forward Looking Statements ,Financial Condition ,Consolidated Statements ,Mind Medicine ,Mind Medicine Mindmed ,